share_log

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga ·  May 20 12:31

Gainers

  • GT Biopharma (NASDAQ:GTBP) shares rose 173.5% to $8.53 during Monday's regular session. The market value of their outstanding shares is at $11.7 million. As per the press release, Q1 earnings came out 3 days ago.
  • NovaBay Pharmaceuticals (AMEX:NBY) shares rose 78.07% to $0.21. The company's market cap stands at $7.9 million.
  • NKGen Biotech (NASDAQ:NKGN) stock moved upwards by 48.66% to $1.67. The market value of their outstanding shares is at $37.4 million.
  • Scorpius Holdings (AMEX:SCPX) shares rose 36.98% to $0.14. The market value of their outstanding shares is at $5.1 million.
  • Scilex Holding (NASDAQ:SCLX) stock moved upwards by 32.22% to $1.19. The market value of their outstanding shares is at $144.1 million.
  • Hims & Hers Health (NYSE:HIMS) shares moved upwards by 31.88% to $19.21. The market value of their outstanding shares is at $4.1 billion.

Losers

  • Virios Therapeutics (NASDAQ:VIRI) shares decreased by 43.1% to $0.2 during Monday's regular session. The company's market cap stands at $3.8 million.
  • Jaguar Health (NASDAQ:JAGX) shares declined by 37.22% to $0.16. The market value of their outstanding shares is at $47.6 million. As per the press release, Q1 earnings came out 4 days ago.
  • DermTech (NASDAQ:DMTK) stock declined by 33.88% to $0.33. The company's market cap stands at $11.5 million. As per the press release, Q1 earnings came out 4 days ago.
  • Akanda (NASDAQ:AKAN) stock decreased by 29.32% to $0.12. The market value of their outstanding shares is at $3.9 million.
  • Aesthetic Medical Intl (NASDAQ:AIH) shares fell 25.86% to $0.37. The company's market cap stands at $17.6 million.
  • Lucy Scientific Discovery (NASDAQ:LSDI) shares decreased by 20.55% to $1.16. The company's market cap stands at $2.0 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment